Amanote Research
Register
Sign In
Increased Orbitofrontal Cortex Activation Associated With “Pro-Obsessive” Antipsychotic Treatment in Patients With Schizophrenia
Journal of Psychiatry and Neuroscience
- Canada
doi 10.1503/jpn.140021
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Psychiatry
Biological Psychiatry
Mental Health
Pharmacology
Date
March 1, 2015
Authors
Unknown
Publisher
Joule Inc.
Related search
Measurement of Treatment Adherence With Antipsychotic Agents in Patients With Schizophrenia
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Augmented Antipsychotic Therapy With Pantogam Active in Patients With Schizophrenia
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
Psychiatry
Mental Health
Neurology
Treatment Adherence and Social Functioning in Patients Diagnosed With Schizophrenia and Treated With Antipsychotic Depot Medication
Medicine and Pharmacy Reports
Medicine
Clinical and Psychosocial Remission in Schizophrenia: Correlations With Antipsychotic Treatment
BMC Psychiatry
Psychiatry
Mental Health
Antipsychotic Treatment Patterns and Hospitalizations Among Adults With Schizophrenia
Schizophrenia Research
Psychiatry
Mental Health
Biological Psychiatry
Antipsychotic-Free Status in Community-Dwelling Patients With Schizophrenia in China
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Antipsychotic Patterns of Use in Patients With Schizophrenia: Polypharmacy Versus Monotherapy
BMC Psychiatry
Psychiatry
Mental Health
Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
Frontiers in Psychiatry
Psychiatry
Mental Health
Gyrification Connectomes in Unmedicated Patients With Schizophrenia and Following a Short Course of Antipsychotic Drug Treatment
Frontiers in Psychiatry
Psychiatry
Mental Health